These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group. Norris SJ Microbiol Rev; 1993 Sep; 57(3):750-79. PubMed ID: 8246847 [TBL] [Abstract][Full Text] [Related]
27. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates. Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635 [TBL] [Abstract][Full Text] [Related]
28. The pattern and level of cytokines secreted by Th1 and Th2 lymphocytes of syphilitic patients correlate to the progression of the disease. Podwinska J; Lusiak M; Zaba R; Bowszyc J FEMS Immunol Med Microbiol; 2000 May; 28(1):1-14. PubMed ID: 10767602 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the humoral immune response to Treponema pallidum in the different stages of untreated human syphilis. Moskophidis M Zentralbl Bakteriol; 1989 Jul; 271(2):171-9. PubMed ID: 2673265 [TBL] [Abstract][Full Text] [Related]
31. Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum. Hanff PA; Bishop NH; Miller JN; Lovett MA J Immunol; 1983 Oct; 131(4):1973-7. PubMed ID: 6352809 [TBL] [Abstract][Full Text] [Related]
33. Lymphocyte transformation and the effect of circulating immune complexes in humans with syphilis. Folds JD; Maret SM; Rauchbach AS Sex Transm Dis; 1982; 9(3):109-14. PubMed ID: 6755769 [TBL] [Abstract][Full Text] [Related]
34. Cyclophosphamide-sensitive activity of suppressor T cells during treponemal infection. Tabor DR; Kiel DP; Jacobs RF Immunology; 1987 Sep; 62(1):127-32. PubMed ID: 2958405 [TBL] [Abstract][Full Text] [Related]
35. Role of L3T4+ and 38+ T-cell subsets in resistance against infection with Treponema pallidum subsp. pertenue in hamsters. Liu H; Alder JD; Steiner BM; Stein-Streilein J; Lim L; Schell RF Infect Immun; 1991 Feb; 59(2):529-36. PubMed ID: 1987070 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits. Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700 [TBL] [Abstract][Full Text] [Related]
37. Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests. From E; Thestrup-Pedersen K; Thulin H Br J Vener Dis; 1976 Aug; 52(4):224-9. PubMed ID: 786437 [TBL] [Abstract][Full Text] [Related]
38. The ability of peripheral blood mononuclear cells of rabbits infected with Treponema pallidum to produce IL-2. Podwińska J; Zaba R; Chomik M; Bowszyc J FEMS Immunol Med Microbiol; 1993 Oct; 7(3):257-64. PubMed ID: 8275056 [TBL] [Abstract][Full Text] [Related]
39. [Role of immunological response of the cellular type in the protection of the body against Treponema pallidum infection]. Podwińska J Postepy Hig Med Dosw; 1985; 39(1):46-84. PubMed ID: 3898048 [No Abstract] [Full Text] [Related]
40. Molecular analysis of immunoglobulins M and G immune response to protein antigens of Treponema pallidum in human syphilis. Moskophidis M; Müller F Infect Immun; 1984 Jan; 43(1):127-32. PubMed ID: 6360891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]